|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Held-to-maturity (fair value $70,359 and $77,874, respectively) | ||||||||||||||||||||
| Available-for-sale ($292 and $858 pledged as collateral, respectively) | ||||||||||||||||||||
| Investment securities | ||||||||||||||||||||
| Held-to-maturity (fair value $64,622 and $67,079, respectively) | ||||||||||||||||||||
| Available-for-sale ($265 and $294 pledged as collateral, respectively) | ||||||||||||||||||||
| Loans held for sale (including $2,645 and $2,353 of mortgage loans carried at fair value, respectively) | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Commercial | ||||||||||||||||||||
| Commercial Real Estate | ||||||||||||||||||||
| Residential Mortgages | ||||||||||||||||||||
| Consumer | ||||||||||||||||||||
| Credit card | ||||||||||||||||||||
| Total loans | ||||||||||||||||||||
| Less allowance for loan losses | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Total loans | ||||||||||||||||||||
| Less allowance for loan losses | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Premises and equipment | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets | ||||||||||||||||||||
| Other assets (including $2,714 and $2,585 of trading securities at fair value pledged as collateral, respectively) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing (including $13 and $718 of time deposits carried at fair value, respectively) | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Long-term debt (including $1,904 and $1,414 of long-term debt carried at fair value, respectively) | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Common stock, $.01 par value per share, authorized: 4,000,000,000 shares; issued: 6/30/26 and 12/31/25—2,125,725,742 shares | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Less cost of common stock in treasury: 6/30/26—567,916,191 shares; 12/31/25—570,328,105 shares | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total U.S. Bancorp shareholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity |
Loading...
